By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BeiGene Co.,Ltd 

No.30 Science Park Road
Zhong-Guan-Cun Life Science Park
Changping District  Beijing    China
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
BeiGene Co.,Ltd Receives Clinical Milestone Payment For Development Of BGB-290 9/15/2014 8:14:20 AM
BeiGene Co.,Ltd Signs China CMO Deal With Boehringer Ingelheim Corporation 9/4/2014 2:41:40 PM
BeiGene Co.,Ltd Expands Management Team With Two Strategic Senior Positions 8/27/2014 9:08:28 AM
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-3111 8/26/2014 10:32:17 AM
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-290 7/7/2014 10:11:17 AM
BeiGene Co.,Ltd Receives $5 Million Clinical Milestone Payment For Development Of BGB-283 5/5/2014 9:46:16 AM
BeiGene Co.,Ltd Announces Addition Of Dr. Ronald Levy To Scientific Advisory Board 3/3/2014 7:31:56 AM
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-283 12/19/2013 9:53:05 AM
Week in Review: BeiGene Co.,Ltd Out-Licenses Novel Cancer Drug to Merck Serono 11/18/2013 10:29:30 AM
BeiGene Co.,Ltd, Merck Serono Add $232 Million+ R&D Deal To Growing Cancer Partnership 11/13/2013 6:46:05 AM
12
//-->